Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center

BACKGROUND: Induction therapy regimens classified as conventional immunosuppressive agents and lower doses of conventional agents combined with antibodies against T-cell antigens have been purposed to prevent acute rejection after renal transplantation. Various induction agents with different doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalafi-Nezhad, A., Sagheb, M. M., Amirmoezi, F., Jowkar, Z., Dehghanian, A. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644567/
https://www.ncbi.nlm.nih.gov/pubmed/26576260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644567/
https://www.ncbi.nlm.nih.gov/pubmed/26576260

Ejemplares similares